Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12Gastrointestinal 4Gynecologic 2NET 1Genitourinary 1Endocrine 1Dermatologic 1Breast 1

Conditions

Neuroendocrine Tumors 3Vipoma 2Somatostatinoma 2Neuroblastoma 2Neoplasms 2Insulinoma 2Glucagonoma 2Gastrinoma 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Familial ependymoma 1Fallopian Tube Neoplasms 1

Interventions

Radiosurgery 4Paclitaxel 4atezolizumab 3Nivolumab 3selpercatinib 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Irinotecan 2Carboplatin 2vandetanib 1taxane 1sargramostim 1romidepsin 1repotrectinib 1pralsetinib 1pentetreotide 1niraparib 1liposomal doxorubicin 1dostarlimab 1aldesleukin 1Vinorelbine 1Topotecan 1Thalidomide 1Temozolomide 1Specimen Handling 1Rose Bengal 1Radiation 1RRx-001 1Quality of Life 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Oxaliplatin × Endocrine × Clear all
NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

University of California, San Francisco

Phase 2/3 Terminated
36 enrolled 14 charts
EndocrineNETThoracic

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡